Patent · US Active

Treatment of facioscapulohumeral dystrophy

US10385338B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 8, 2016
Grant dateAug 20, 2019
Priority date
Expiry dateFeb 8, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/532
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to nucleic acids, compositions and methods for the treatment of facioscapulohumeral dystrophy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.